Dr. Hepgur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
201 E Sample Road
Deerfield Beach, FL 33064Phone+1 954-786-6660- Is this information wrong?
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2011 - 2014
- University at BuffaloResidency, Internal Medicine, 2008 - 2011
- Istanbul University FomClass of 1999
Certifications & Licensure
- FL State Medical License 2014 - 2026
- CA State Medical License 2010 - 2024
- TN State Medical License 2014 - 2019
- AL State Medical License Active through 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Best Research Presentation Award USC Keck School of Medicine, 2014
- Conquer Cancer Foundation Merit Award American Society of Medical Oncology, 2013
Publications & Presentations
PubMed
- 1 citationsDurable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal.Tanya B. Dorff, Cy Wilkins, Mehmet Hepgur, David I. Quinn> ;Clinical Genitourinary Cancer. 2014 Apr 1
- 6 citationsAtypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.Preeti Chaudhary, Mehmet Hepgur, Sarmen Sarkissian, Richard J.H. Smith, Ilene C. Weitz> ;Blood Transfusion = Trasfusione Del Sangue. 2014 Jan 1
- 15 citationsTivozanib in the treatment of renal cell carcinomaMehmet Hepgur, Sarmad Sadeghi, Tanya B. Dorff, David I. Quinn> ;Biologics. 2013 Jun 11
- Join now to see all
Journal Articles
- Evaluation of Skull Thickness and Insertion Torque at the Halo Pin Insertion Areas in the ElderlyEbraheim N, Hepgur M, The Spine Journal
- Solitary Splenic Metastasis from Primary Non Small Cell Carcinoma of the LungHepgur M Noor M DePlato A, International Journal of Hematology and Oncology
Abstracts/Posters
- Dynamic changes in biomarkers for immune response to sipuleucel-t (SipT) for metastatic castrate-resistant prostate cancer (mCRPC)Mehmet Faith Hepgur, Tanya B. Dorff, Jie Cai, Mary Reed, Betty Chan, David I. Quinn;, J Clin Oncol 33, 2015 (suppl 7; abstr 181)
- Identification of biological and inflammatory markers for predicting clinical responses to Sipuleucel-T in mCRPC.Hepgur M, Dorff TB, Cai J, Pinski JK, Reed M, Luther M, Chan M, Quinn DI., ASCO GU Cancers Symposium, 2/2014
- Clinical and biological factors for immune response to Sipuleucel-T for metastatic castrate resistant prostate cancer.Hepgur M, Dorff TB, Cai J, Pinski JK, Reed M, Luther M, Chan M, Quinn DI., ASCO GU Cancers Symposium, 2/2014
- Join now to see all
Press Mentions
- Broward Health and Voluntis Launch a New Clinical Evaluation Program on Digital Therapeutics for Metastatic Breast CancerMarch 18th, 2021
Committees
- Peer-reviewer, OncoTargets and Therapy 2014 - Present
- Peer-reviewer, ImmunoTargets and Therapy 2014 - Present
Research History
- Research AssociateRoswell Park Cancer Institute Division of Bone Marrow Transplantation2009 - 2009
Other Languages
- Turkish
External Links
- Google Scholarhttp://scholar.google.com.tw/citations?user=69P0RfgAAAAJ&hl=en
- Pubmedhttp://www.ncbi.nlm.nih.gov/pubmed/?term=hepgur
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: